[1]
Czimbalmos C, Csecs I, Toth A, Kiss O, Suhai FI, Sydo N, Dohy Z, Apor A, Merkely B, Vago H. The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart. PloS one. 2019:14(2):e0211624. doi: 10.1371/journal.pone.0211624. Epub 2019 Feb 14
[PubMed PMID: 30763323]
[2]
Aljeaid D, Sanchez AI, Wakefield E, Chadwell SE, Moore N, Prada CE, Zhang W. Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy. American journal of medical genetics. Part A. 2019 Apr:179(4):608-614. doi: 10.1002/ajmg.a.61072. Epub 2019 Feb 14
[PubMed PMID: 30762279]
[3]
Song C, Wang S, Guo Y, Zheng X, Lu J, Fang X, Wang S, Huang X. Preoperative NT-proBNP Predicts Midterm Outcome After Septal Myectomy. Journal of the American Heart Association. 2019 Feb 19:8(4):e011075. doi: 10.1161/JAHA.118.011075. Epub
[PubMed PMID: 30760079]
[4]
Borer JS,Atar D,Marciniak T,Kim MH,Serebruany V, Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights. Thrombosis and haemostasis. 2019 Feb 13;
[PubMed PMID: 30759487]
[5]
Fernández-Ruiz I. Modulating myosin function to treat hypertrophic cardiomyopathy. Nature reviews. Cardiology. 2019 Apr:16(4):201. doi: 10.1038/s41569-019-0170-9. Epub
[PubMed PMID: 30755739]
[6]
van Driel B, Nijenkamp L, Huurman R, Michels M, van der Velden J. Sex differences in hypertrophic cardiomyopathy: new insights. Current opinion in cardiology. 2019 May:34(3):254-259. doi: 10.1097/HCO.0000000000000612. Epub
[PubMed PMID: 30747730]
Level 3 (low-level) evidence
[7]
Marrocco V, Bogomolovas J, Ehler E, Dos Remedios CG, Yu J, Gao C, Lange S. PKC and PKN in heart disease. Journal of molecular and cellular cardiology. 2019 Mar:128():212-226. doi: 10.1016/j.yjmcc.2019.01.029. Epub 2019 Feb 8
[PubMed PMID: 30742812]
[8]
Walsh R,Mazzarotto F,Whiffin N,Buchan R,Midwinter W,Wilk A,Li N,Felkin L,Ingold N,Govind R,Ahmad M,Mazaika E,Allouba M,Zhang X,de Marvao A,Day SM,Ashley E,Colan SD,Michels M,Pereira AC,Jacoby D,Ho CY,Thomson KL,Watkins H,Barton PJR,Olivotto I,Cook SA,Ware JS, Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy. Genome medicine. 2019 Jan 29;
[PubMed PMID: 30696458]
Level 3 (low-level) evidence
[9]
Raffa GM, Romano G, Falletta C, Morsolini M, Turrisi M, Gentile G, Nugara C, Scarlata M, Clemenza F, Pilato M. [Surgical management of hypertrophic obstructive cardiomyopathy: the role of mitral valve]. Giornale italiano di cardiologia (2006). 2019 Feb:20(2):109-116. doi: 10.1714/3093.30858. Epub
[PubMed PMID: 30747926]
[10]
Modaff DS, Hegde SM, Wyman RA, Rahko PS. Usefulness of Focused Screening Echocardiography for Collegiate Athletes. The American journal of cardiology. 2019 Jan 1:123(1):169-174. doi: 10.1016/j.amjcard.2018.09.012. Epub 2018 Sep 26
[PubMed PMID: 30348435]
[11]
Emet S, Dadashov M, Sonsoz MR, Cakir MO, Yilmaz M, Elitok A, Bilge AK, Mercanoglu F, Oncul A, Adalet K, Onur I. Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy. The American journal of the medical sciences. 2018 Dec:356(6):537-543. doi: 10.1016/j.amjms.2018.08.013. Epub 2018 Aug 29
[PubMed PMID: 30342718]
[12]
Hinojar R,Zamorano JL,Fernández-Méndez M,Esteban A,Plaza-Martin M,González-Gómez A,Carbonell A,Rincón LM,Nácher JJJ,Fernández-Golfín C, Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy. The international journal of cardiovascular imaging. 2019 Jan 31;
[PubMed PMID: 30706353]
[13]
Bogachev-Prokophiev A, Afanasyev AV, Zheleznev S, Pivkin A, Sharifulin R, Kozmin D, Karaskov A. Septal Myectomy With Vs Without Subvalvular Apparatus Intervention in Patients With Hypertrophic Obstructive Cardiomyopathy: A Prospective Randomized Study. Seminars in thoracic and cardiovascular surgery. 2019 Autumn:31(3):424-431. doi: 10.1053/j.semtcvs.2019.01.011. Epub 2019 Jan 11
[PubMed PMID: 30641129]
Level 1 (high-level) evidence